why choose us

First received: August 5, 2022

Clinical Trial: Early Detection of de Novo Cancer in Liver Transplant Recipients

Study Status: Completed

Recruit Status: Completed

Condition: De Novo Cancer
Liver Transplant Disorder

Study Type: Observational


Official Title: Early Detection of de Novo Cancer in Liver Transplant Recipients - a ScandiaTransplant Collaboration

Brief Summary: Background The risk of cancer in liver transplant recipients is twice the cancer risk in the general population and de novo cancers are one of the leading causes of death after liver transplantation. The immunosuppressive medication, used to prevent organ rejection, is considered a key factor increasing the risk of de novo cancer.Objectives I. Determine prevalence and incidence of de novo cancer in liver transplant recipients and build an algorithm to identify high-risk individuals II. Investigate if opportunistic…

Read more